These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 16105523

  • 1. Is transarterial chemoembolization necessary before liver transplantation for hepatocellular carcinoma?
    Pérez Saborido B, Meneu JC, Moreno E, García I, Moreno A, Fundora Y.
    Am J Surg; 2005 Sep; 190(3):383-7. PubMed ID: 16105523
    [Abstract] [Full Text] [Related]

  • 2. The effect of preoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma.
    Zhang Z, Liu Q, He J, Yang J, Yang G, Wu M.
    Cancer; 2000 Dec 15; 89(12):2606-12. PubMed ID: 11135222
    [Abstract] [Full Text] [Related]

  • 3. Preoperative chemoembolization in patients with hepatocellular carcinoma undergoing liver transplantation: influence of emergent versus elective procedures on patient survival and tumor recurrence rate.
    Stockland AH, Walser EM, Paz-Fumagalli R, McKinney JM, May GR.
    Cardiovasc Intervent Radiol; 2007 Dec 15; 30(5):888-93. PubMed ID: 17619218
    [Abstract] [Full Text] [Related]

  • 4. Role of mesohepatectomy with or without transcatheter arterial chemoembolization for large centrally located hepatocellular carcinoma.
    Chen XP, Hu DY, Zhang ZW, Zhang BX, Chen YF, Zhang WG, Qiu FZ.
    Dig Surg; 2007 Dec 15; 24(3):208-13. PubMed ID: 17522469
    [Abstract] [Full Text] [Related]

  • 5. Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome.
    Graziadei IW, Sandmueller H, Waldenberger P, Koenigsrainer A, Nachbaur K, Jaschke W, Margreiter R, Vogel W.
    Liver Transpl; 2003 Jun 15; 9(6):557-63. PubMed ID: 12783395
    [Abstract] [Full Text] [Related]

  • 6. [Influence of treatment of hepatocellular carcinoma before liver transplantation on post transplant tumor recurrence and survival].
    Díaz-Sánchez A, Matilla A, Núñez O, Merino B, Peligros I, Rincón D, Salcedo M, Lo Iacono O, Vega Catalina M, Clemente G, Bañares R.
    Gastroenterol Hepatol; 2010 Mar 15; 33(3):155-64. PubMed ID: 19945770
    [Abstract] [Full Text] [Related]

  • 7. Response to preoperative chemoembolization correlates with outcome after liver transplantation in patients with hepatocellular carcinoma.
    Millonig G, Graziadei IW, Freund MC, Jaschke W, Stadlmann S, Ladurner R, Margreiter R, Vogel W.
    Liver Transpl; 2007 Feb 15; 13(2):272-9. PubMed ID: 17256758
    [Abstract] [Full Text] [Related]

  • 8. Preoperative transcatheter arterial chemoembolization reduces long-term survival rate after hepatic resection for resectable hepatocellular carcinoma.
    Sasaki A, Iwashita Y, Shibata K, Ohta M, Kitano S, Mori M.
    Eur J Surg Oncol; 2006 Sep 15; 32(7):773-9. PubMed ID: 16797156
    [Abstract] [Full Text] [Related]

  • 9. Role of transarterial chemoembolization for hepatocellular carcinoma before liver transplantation with special consideration of tumor necrosis.
    Schaudt A, Kriener S, Schwarz W, Wullstein C, Zangos S, Vogl T, Mehrabi A, Fonouni H, Bechstein WO, Golling M.
    Clin Transplant; 2009 Dec 15; 23 Suppl 21():61-7. PubMed ID: 19930318
    [Abstract] [Full Text] [Related]

  • 10. A prospective, randomized, controlled trial of preoperative transarterial chemoembolization for resectable large hepatocellular carcinoma.
    Zhou WP, Lai EC, Li AJ, Fu SY, Zhou JP, Pan ZY, Lau WY, Wu MC.
    Ann Surg; 2009 Feb 15; 249(2):195-202. PubMed ID: 19212170
    [Abstract] [Full Text] [Related]

  • 11. Influence of transcatheter arterial chemoembolization on the prognosis after hepatectomy for hepatocellular carcinoma in patients with severe liver dysfunction.
    Kaibori M, Tanigawa N, Matsui Y, Saito T, Uchida Y, Ishizaki M, Tanaka H, Kamiyama Y.
    Anticancer Res; 2006 Feb 15; 26(5B):3685-92. PubMed ID: 17094386
    [Abstract] [Full Text] [Related]

  • 12. [Expression and prognostic value of proliferating cell nuclear antigen in hepatocellular carcinoma patients received preoperative transcatheter arterial chemoembolization].
    Guo RP, Yu WS, Wei W.
    Ai Zheng; 2008 Feb 15; 27(2):201-5. PubMed ID: 18279622
    [Abstract] [Full Text] [Related]

  • 13. Combination therapy with transarterial chemoembolization and interferon-alpha compared with transarterial chemoembolization alone for hepatitis B virus related unresectable hepatocellular carcinoma.
    Li M, Lu C, Cheng J, Zhang J, Cao C, Xu J, Xu J, Pan H, Zhong B, Tucker S, Wang D.
    J Gastroenterol Hepatol; 2009 Aug 15; 24(8):1437-44. PubMed ID: 19486255
    [Abstract] [Full Text] [Related]

  • 14. [A comparison of patients with hepatocellular carcinoma between a short-term (less than 6 months) survival group and a long-term (over 24 months) survival group after treatment with transcatheter arterial chemoembolization].
    Kang IK, Kim SW, Hahn SH, Cho SC, Gham CW, Lee DH.
    Taehan Kan Hakhoe Chi; 2002 Jun 15; 8(2):189-200. PubMed ID: 12499805
    [Abstract] [Full Text] [Related]

  • 15. [Influence of different treatment modalities on survival of patients with two -stage resection of unresectable hepatocellular carcinoma].
    Fan J, Wu Z, Tang Z.
    Zhonghua Wai Ke Za Zhi; 2001 Oct 15; 39(10):745-8. PubMed ID: 16201184
    [Abstract] [Full Text] [Related]

  • 16. Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma.
    Otto G, Herber S, Heise M, Lohse AW, Mönch C, Bittinger F, Hoppe-Lotichius M, Schuchmann M, Victor A, Pitton M.
    Liver Transpl; 2006 Aug 15; 12(8):1260-7. PubMed ID: 16826556
    [Abstract] [Full Text] [Related]

  • 17. [The effect of preoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma].
    Zhang Z, Wu M, Liu Q.
    Zhonghua Zhong Liu Za Zhi; 1999 May 15; 21(3):214-6. PubMed ID: 11776840
    [Abstract] [Full Text] [Related]

  • 18. [Exploration of indication of prophylactic transcatheter arterial chemoembolization on postoperative recurrence of hepatocellular carcinoma].
    Wang QX, Yan JJ, Zhou FG, Shen J, Yan YQ.
    Zhonghua Wai Ke Za Zhi; 2009 May 15; 47(10):748-51. PubMed ID: 19615209
    [Abstract] [Full Text] [Related]

  • 19. [Comparison of radiofrequency ablation and transarterial chemoembolization for the treatment of a single hepatocellular carcinoma smaller than 4 cm].
    Yang MJ, An SY, Moon EJ, Lee MS, Hwang JA, Cheong JY, Won JH, Kim JK, Wang HJ, Cho SW.
    Korean J Hepatol; 2009 Dec 15; 15(4):474-85. PubMed ID: 20037266
    [Abstract] [Full Text] [Related]

  • 20. The effect of preoperative transarterial chemoembolization of resectable hepatocellular carcinoma on clinical and economic outcomes.
    Lee KT, Lu YW, Wang SN, Chen HY, Chuang SC, Chang WT, Shi HY, Ker CG, Chiu HC.
    J Surg Oncol; 2009 May 01; 99(6):343-50. PubMed ID: 19226530
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.